ES2058139T3 - Compuestos complejos de bioflavonoides con fosfolipidos, su preparacion y uso, y composiciones farmaceuticas y cosmeticas que los contienen. - Google Patents
Compuestos complejos de bioflavonoides con fosfolipidos, su preparacion y uso, y composiciones farmaceuticas y cosmeticas que los contienen.Info
- Publication number
- ES2058139T3 ES2058139T3 ES88100022T ES88100022T ES2058139T3 ES 2058139 T3 ES2058139 T3 ES 2058139T3 ES 88100022 T ES88100022 T ES 88100022T ES 88100022 T ES88100022 T ES 88100022T ES 2058139 T3 ES2058139 T3 ES 2058139T3
- Authority
- ES
- Spain
- Prior art keywords
- phospholipids
- bioflavonoids
- pharmaceutical
- preparation
- adequate
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 150000003904 phospholipids Chemical class 0.000 title abstract 2
- 239000000203 mixture Substances 0.000 title 2
- 229940093797 bioflavonoids Drugs 0.000 title 1
- 239000002537 cosmetic Substances 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 3
- 229930003935 flavonoid Natural products 0.000 abstract 2
- 235000017173 flavonoids Nutrition 0.000 abstract 2
- -1 FLAVONOIDS COMPOUNDS Chemical class 0.000 abstract 1
- 150000002215 flavonoids Chemical class 0.000 abstract 1
- 230000001225 therapeutic effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/06—Phosphorus compounds without P—C bonds
- C07F9/08—Esters of oxyacids of phosphorus
- C07F9/09—Esters of phosphoric acids
- C07F9/10—Phosphatides, e.g. lecithin
- C07F9/106—Adducts, complexes, salts of phosphatides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/54—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
- A61K47/543—Lipids, e.g. triglycerides; Polyamines, e.g. spermine or spermidine
- A61K47/544—Phospholipids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/55—Phosphorus compounds
- A61K8/553—Phospholipids, e.g. lecithin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/60—Sugars; Derivatives thereof
- A61K8/602—Glycosides, e.g. rutin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9771—Ginkgophyta, e.g. Ginkgoaceae [Ginkgo family]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9789—Magnoliopsida [dicotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
- C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
- C07H17/06—Benzopyran radicals
- C07H17/065—Benzo[b]pyrans
- C07H17/07—Benzo[b]pyran-4-ones
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Organic Chemistry (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Birds (AREA)
- Biotechnology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Biophysics (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Mycology (AREA)
- Botany (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Genetics & Genomics (AREA)
- Dermatology (AREA)
- Rheumatology (AREA)
- Heart & Thoracic Surgery (AREA)
- Pain & Pain Management (AREA)
- Cardiology (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Obesity (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Cosmetics (AREA)
- Saccharide Compounds (AREA)
- Medicines Containing Plant Substances (AREA)
- Pyrane Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
COMPUESTOS COMPLEJOS DE FLAVONOIDES CON FOSFOLIPIDOS, CARACTERIZADO POR ALTA LIPOFILIA Y BIODISPONIBILIDAD Y PROPIEDADES TERAPEUTICAS MEJORADAS EN COMPARACION CON LOS FLAVONOIDES LIBRES NO COMPLEJADOS, LOS COMPUESTOS DE LA INVENCION SON ADECUADOS PARA USO COMO PRINCIPIO ACTIVO EN COMPOSICIONES FARMACEUTICAS Y COSMETICAS.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IT19081/87A IT1201149B (it) | 1987-01-14 | 1987-01-14 | Complessi di bioflavonoidi con fosfolipidi,loro preparazione,uso e composizioni farmaceutici e cosmetiche |
Publications (1)
Publication Number | Publication Date |
---|---|
ES2058139T3 true ES2058139T3 (es) | 1994-11-01 |
Family
ID=11154385
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES88100022T Expired - Lifetime ES2058139T3 (es) | 1987-01-14 | 1988-01-04 | Compuestos complejos de bioflavonoides con fosfolipidos, su preparacion y uso, y composiciones farmaceuticas y cosmeticas que los contienen. |
Country Status (8)
Country | Link |
---|---|
US (1) | US5043323A (es) |
EP (1) | EP0275005B1 (es) |
JP (1) | JP2848827B2 (es) |
AT (1) | ATE92929T1 (es) |
DE (1) | DE3883016T2 (es) |
ES (1) | ES2058139T3 (es) |
HK (1) | HK160995A (es) |
IT (1) | IT1201149B (es) |
Families Citing this family (103)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IT1201151B (it) * | 1987-01-14 | 1989-01-27 | Indena Spa | Complessi fosfolipidici con estratti da vitis vinifera,procedimento per la loro preparazione e composizioni che li cntengono |
US5637302A (en) * | 1988-09-20 | 1997-06-10 | Indena Spa | Extracts of Ginkgo biloba and their methods of preparation |
FR2639828B1 (fr) * | 1988-12-01 | 1993-11-05 | Lvmh Recherche | Utilisation du kaempferol et de certains de ses derives pour la preparation d'une composition cosmetique ou pharmaceutique |
IT1238684B (it) * | 1990-02-09 | 1993-09-01 | Indena Spa | Derivati del bilobalide,loro usi e formulazioni che li contegono |
FR2661830B1 (fr) * | 1990-05-11 | 1992-09-04 | Corbiere Jerome | Nouvelle compositions pharmaceutiques a base de flavonoside. |
DK0464297T3 (da) * | 1990-07-05 | 1995-10-09 | Indena Spa | Komplekser af neolignanderivater med phospholipider, anvendelsen deraf samt farmaceutiske og kosmetiske formuleringer indeholdende disse |
FR2667505B1 (fr) * | 1990-10-08 | 1993-01-15 | Thorel Jean Noel | Bases pour serums a usage cosmetique. |
FR2668705A1 (fr) * | 1990-11-06 | 1992-05-07 | Bouchara Sa | Nouvelles preparations dermiques a action phlebotonique et leur procede de preparation. |
FR2669537B1 (fr) * | 1990-11-28 | 1993-02-19 | Oreal | Composition amincissante a base d'alpha-2-bloqueurs. |
US5455232A (en) * | 1992-02-04 | 1995-10-03 | Piljac; Goran | Pharmaceutical preparation based on rhamnolipid |
US5401728A (en) * | 1992-04-02 | 1995-03-28 | Simon; John A. | Lecithin based topical liniment |
GB9211659D0 (en) * | 1992-06-02 | 1992-07-15 | Indena Spa | New alkaloid derivatives,their use and pharmaceutical formulations containing them |
FR2692145B1 (fr) * | 1992-06-10 | 1995-05-05 | Bellon Labor Sa Roger | Nouvelle composition à usage topique contenant de la diosmine. |
WO1994003215A1 (en) * | 1992-07-30 | 1994-02-17 | Andrew Stone | Dialysis system, method and filtrate solution composition |
FR2697159B1 (fr) * | 1992-10-22 | 1995-01-13 | Oreal | Composition cosmétique ou dermo-pharmaceutique contenant en association un lauroylméthionate d'un amino acide basique et au moins un polyphénol. |
FR2699818B1 (fr) * | 1992-12-24 | 1995-02-03 | Oreal | Composition cosmétique ou pharmaceutique contenant en association un polyphénol et un extrait de gingko. |
IL105244A (en) * | 1993-03-31 | 2003-07-31 | Dpharm Ltd | Prodrugs with enhanced penetration into cells |
US6413949B1 (en) * | 1995-06-07 | 2002-07-02 | D-Pharm, Ltd. | Prodrugs with enhanced penetration into cells |
HUT67748A (en) * | 1993-07-27 | 1995-04-28 | Biogal Gyogyszergyar | Hair tonic composition |
FR2719468B1 (fr) * | 1994-05-05 | 1996-05-31 | Oreal | Compositions cosmétiques à base de certains bioflavonoïdes et utilisations notamment dans le domaine capillaire. |
FR2719467B1 (fr) * | 1994-05-05 | 1996-05-31 | Oreal | Utilisation de flavonoïdes pour préserver et/ou renforcer les propriétés mécaniques des cheveux et procédé de protection des cheveux utilisant ces composés. |
FR2726469B1 (fr) * | 1994-11-08 | 1996-12-13 | Adir | Composition pharmaceutique pour l'administration orale de flavonoides |
DE4444238A1 (de) * | 1994-12-13 | 1996-06-20 | Beiersdorf Ag | Kosmetische oder dermatologische Wirkstoffkombinationen aus Zimtsäurederivaten und Flavonglycosiden |
EP0813418A2 (en) * | 1995-03-08 | 1997-12-29 | Parfums Christian Dior | Composition for treating skin conditions comprising an inhibitor of skin iso-phosphodiesterase |
US6313106B1 (en) | 1995-06-07 | 2001-11-06 | D-Pharm Ltd. | Phospholipid derivatives of valproic acid and mixtures thereof |
EP1245230A3 (en) * | 1995-06-23 | 2003-11-26 | Advanced Life Sciences Inc. | Amentoflavone as an antiviral agent |
FR2736829B1 (fr) * | 1995-07-20 | 1997-09-12 | Oreal | Composition pour lutter contre les taches et/ou le vieillissement de la peau, ses utilisations |
US5571503A (en) * | 1995-08-01 | 1996-11-05 | Mausner; Jack | Anti-pollution cosmetic composition |
US5891465A (en) * | 1996-05-14 | 1999-04-06 | Biozone Laboratories, Inc. | Delivery of biologically active material in a liposomal formulation for administration into the mouth |
FR2749303B1 (fr) * | 1996-05-30 | 1998-08-07 | Berkem Sa | Procede d'extraction de polyphenols catechiques a partir de potentilles extrait obtenu et son utilisation |
FR2755012A1 (fr) * | 1996-10-31 | 1998-04-30 | Slow Age Creations | Composition topique destinee a augmenter la souplesse et l'elasticite du buste pendant la phase premenstruelle |
DE69826253D1 (de) | 1997-03-20 | 2004-10-21 | Coventry Group Ltd | Nährungsergänzungsmittel für kardiovasküläre gesundheit |
JP4231559B2 (ja) * | 1997-04-23 | 2009-03-04 | オリザ油化株式会社 | リポキシゲナーゼ阻害剤 |
US8039026B1 (en) | 1997-07-28 | 2011-10-18 | Johnson & Johnson Consumer Companies, Inc | Methods for treating skin pigmentation |
US5958104A (en) * | 1997-09-11 | 1999-09-28 | Nonomura; Arthur M. | Methods and compositions for enhancing plant growth |
US6312703B1 (en) | 1998-02-06 | 2001-11-06 | Lecigel, Llc | Compressed lecithin preparations |
CA2323364A1 (en) * | 1998-03-16 | 1999-09-23 | The Procter & Gamble Company | Compositions for regulating skin appearance |
US20080153761A1 (en) * | 1998-04-08 | 2008-06-26 | Theoharides Theoharis C | Compositions for protection against superficial vasodilator flush syndrome, and methods of use |
DE19829516B4 (de) * | 1998-07-02 | 2004-08-26 | Dr. Willmar Schwabe Gmbh & Co. Kg | Wasserlöslicher nativer Trockenextrakt aus Gingko biloba mit hohem Gehalt an Terpenoiden und Flavonglykosiden |
US8093293B2 (en) | 1998-07-06 | 2012-01-10 | Johnson & Johnson Consumer Companies, Inc. | Methods for treating skin conditions |
US8106094B2 (en) | 1998-07-06 | 2012-01-31 | Johnson & Johnson Consumer Companies, Inc. | Compositions and methods for treating skin conditions |
US6750229B2 (en) | 1998-07-06 | 2004-06-15 | Johnson & Johnson Consumer Companies, Inc. | Methods for treating skin pigmentation |
DE19845319A1 (de) * | 1998-10-01 | 2000-04-06 | Beiersdorf Ag | Verwendung von oberflächenaktiven Substanzen zur Stabilisierung von Flavonen, Flavanonen bzw. Flavonoiden, synergistische Gemische aus Flavonen, Flavanonen bzw. Flavonoiden und oberflächenaktiven Substanzen sowie kosmetische und dermatologische Zubereitungen mit einem Gehalt an solchen Gemischen |
IT1304183B1 (it) * | 1998-12-18 | 2001-03-08 | Indena Spa | Complessi di proantocianidina a2 con fosfolipidi come agentiantiaterosclerotici. |
US7985404B1 (en) | 1999-07-27 | 2011-07-26 | Johnson & Johnson Consumer Companies, Inc. | Reducing hair growth, hair follicle and hair shaft size and hair pigmentation |
WO2001021608A2 (en) * | 1999-09-23 | 2001-03-29 | Vereniging Voor Christelijk Wetenschappelijk Onderwijs | Novel flavonoids |
US6528042B1 (en) | 1999-10-08 | 2003-03-04 | Galileo Laboratories, Inc. | Compositions of flavonoids for use as cytoprotectants and methods of making and using them |
US6426362B1 (en) * | 1999-10-08 | 2002-07-30 | Galileo Laboratories, Inc. | Formulations of tocopherols and methods of making and using them |
US7309688B2 (en) | 2000-10-27 | 2007-12-18 | Johnson & Johnson Consumer Companies | Topical anti-cancer compositions and methods of use thereof |
DE19962345B4 (de) * | 1999-12-23 | 2005-03-17 | Cognis Deutschland Gmbh & Co. Kg | Kosmetische Mittel mit Pflanzenextrakten aus den Samenhäutchen von Arachis hypogaea L. und Verwendung der Pflanzenextrakte |
GB2368012A (en) * | 2000-10-19 | 2002-04-24 | Nicholas John Larkins | Preparation for the relief of inflammatory disease |
US8431550B2 (en) | 2000-10-27 | 2013-04-30 | Johnson & Johnson Consumer Companies, Inc. | Topical anti-cancer compositions and methods of use thereof |
US6733797B1 (en) * | 2000-11-15 | 2004-05-11 | William K. Summers | Neuroceutical for improving memory and cognitive abilities |
US6555573B2 (en) * | 2000-12-21 | 2003-04-29 | The Quigley Corporation | Method and composition for the topical treatment of diabetic neuropathy |
US7368555B2 (en) * | 2001-01-03 | 2008-05-06 | Ceres, Inc. | Sequence-determined DNA fragments encoding EF-hand calcium-binding proteins |
KR20020069539A (ko) * | 2001-02-26 | 2002-09-05 | 주식회사 두산 | 뇌세포 보호용 조성물 |
US6555143B2 (en) | 2001-02-28 | 2003-04-29 | Johnson & Johnson Consumer Products, Inc. | Legume products |
US7192615B2 (en) | 2001-02-28 | 2007-03-20 | J&J Consumer Companies, Inc. | Compositions containing legume products |
DE60220415T2 (de) | 2001-07-27 | 2008-02-14 | Neptune Technologies & Bioressources Inc., Laval | Flavonoide und mehrfach ungesättigte fettsäuren enthaltende natürliche phospholipide maritimen ursprungs sowie deren anwendungen |
CA2475630C (en) * | 2002-02-12 | 2011-01-18 | Hunza Di Pistolesi Elvira & C. S.A.S. | N-acyl-phosphatidyl-ethanolamines and/or mixtures of n-acyl-ethanolamines with phosphatidic acids or lysophosphatidic acids |
US7314634B2 (en) * | 2002-02-22 | 2008-01-01 | Steven Hernandez | Use of polyphenols to treat skin conditions |
US20040001817A1 (en) * | 2002-05-14 | 2004-01-01 | Giampapa Vincent C. | Anti-aging nutritional supplement |
US7083813B2 (en) * | 2002-11-06 | 2006-08-01 | The Quigley Corporation | Methods for the treatment of peripheral neural and vascular ailments |
ITMI20031789A1 (it) * | 2003-09-19 | 2005-03-20 | Indena Spa | Composizioni farmaceutiche e cosmetiche per il trattamento |
US8052992B2 (en) | 2003-10-22 | 2011-11-08 | Enzymotec Ltd. | Glycerophospholipids containing omega-3 and omega-6 fatty acids and their use in the treatment and improvement of cognitive functions |
US7935365B2 (en) | 2003-10-22 | 2011-05-03 | Enzymotec, Ltd. | Glycerophospholipids for the improvement of cognitive functions |
US20050130937A1 (en) | 2003-10-22 | 2005-06-16 | Enzymotec Ltd. | Lipids containing omega-3 and omega-6 fatty acids |
EP1541037A1 (de) * | 2003-12-04 | 2005-06-15 | Cognis Deutschland GmbH & Co. KG | Zubereitung zur oralen Aufnahme enthaltend Extrakte von Passiflora incarnata |
ATE428312T1 (de) * | 2004-01-29 | 2009-05-15 | Indena Spa | Verwendung von ginkgokomplexen zur verbesserung von kognitiven leistungen und linderung der mentalen ermüdung |
JP5089887B2 (ja) * | 2006-01-23 | 2012-12-05 | 日本精化株式会社 | 生理活性物質含有複合体 |
EP1837030A1 (en) | 2006-03-09 | 2007-09-26 | INDENA S.p.A. | Phospholipid complexes of curcumin having improved bioavailability |
AU2007227535A1 (en) * | 2006-03-15 | 2007-09-27 | Rutgers, The State University Of New Jersey | Hydroxylated polymethoxyflavone compositions |
ITMI20060712A1 (it) * | 2006-04-11 | 2007-10-12 | Fond Irccs Istituto Di Ricovero E Cura ... | Uso di aminaftone per la preparazione di un medicamento per il trattamento delle arteriopatie |
EP1844785A1 (en) | 2006-04-13 | 2007-10-17 | Indena S.P.A. | Phospholipid complexes of olive fruits or leaves extracts having improved bioavailability |
WO2008019985A1 (en) * | 2006-08-14 | 2008-02-21 | Unilever Plc | Method of purifying theaflavins |
JP4757157B2 (ja) * | 2006-09-20 | 2011-08-24 | 日本コルマー株式会社 | 皮膚外用剤 |
CH702736B1 (de) * | 2008-12-31 | 2012-12-14 | Obschestvo S Organichennoi Otvetstvennostju Scient Company Flamena | Phospholipid-Emulsion, die Dihydroquerzetin beinhaltet. |
IT1395351B1 (it) | 2009-07-09 | 2012-09-14 | Axioma Srl | Formulazioni orali ad elevata biodisponibilita' orale costituite da miscele di frazioni lipofile e idrofile ottenute a partire dalla propoli |
KR20230024438A (ko) | 2009-08-26 | 2023-02-20 | 마리 케이 인코포레이티드 | 식물 추출물을 포함하는 국소 피부 케어 제형 |
MX338211B (es) | 2009-10-22 | 2016-03-30 | Api Genesis Llc | Metodos para hacer y utilizar composiciones que comprenden flavonoides. |
US8637569B2 (en) | 2009-10-22 | 2014-01-28 | Api Genesis, Llc | Methods of increasing solubility of poorly soluble compounds and methods of making and using formulations of such compounds |
EP2493478B8 (en) | 2009-10-29 | 2018-03-28 | Acasti Pharma, Inc. | Concentrated therapeutic phospholipid compositions |
IT1397386B1 (it) * | 2010-01-12 | 2013-01-10 | Indena Spa | Composizioni a base di estratti di andrographis paniculata combinati con estratti di ginkgo biloba complessati con fosfolipidi e loro uso. |
US20110262505A1 (en) * | 2010-04-22 | 2011-10-27 | Gina Athwal | Seaweed-derived cosmetic compositions |
CA2849323C (en) * | 2011-10-03 | 2017-02-21 | The Procter & Gamble Company | Hair care compositions and methods of use |
US20140093466A1 (en) | 2012-10-02 | 2014-04-03 | The Procter & Gamble Company | Hair care compositions and methods of use |
DE202011108417U1 (de) | 2011-11-29 | 2012-03-01 | Ruth-Maria Korth | Örtliche und dietätische Kompositionen ohne Etherlipide, Etherphospholipide, Alkylradikale, die geeignet sind für sensible Personen |
US20150110866A1 (en) * | 2012-05-22 | 2015-04-23 | Harold Gordon Cave | Complexes and compositions containing curcumin |
US20150104503A1 (en) * | 2012-05-22 | 2015-04-16 | Harold Gordon Cave | Complexes and compositions containing curcumin |
CN102977164B (zh) * | 2012-11-05 | 2015-09-30 | 河南牧翔动物药业有限公司 | 一种刺五加叶中金丝桃苷的酶辅助提取工艺 |
ITMI20130171A1 (it) | 2013-02-07 | 2014-08-08 | Velleja Res Srl | Composizioni ergogenico-anabolizzanti a base di polygonum fagopyrum |
CN105188850A (zh) | 2013-05-16 | 2015-12-23 | 宝洁公司 | 毛发增稠组合物及使用方法 |
US9132117B2 (en) | 2013-06-17 | 2015-09-15 | Kgk Synergize, Inc | Compositions and methods for glycemic control of subjects with impaired fasting glucose |
US20160175377A1 (en) | 2014-12-19 | 2016-06-23 | Umm Al-Qura University | Formulation and functionality of phenolipids for novel foods and pharmaceuticals |
CN104983761A (zh) * | 2015-06-15 | 2015-10-21 | 中国科学院长春应用化学研究所 | 一种刺五加叶总黄酮磷脂复合物及其制备方法以及制剂 |
US10898537B2 (en) | 2015-07-31 | 2021-01-26 | Delivra Inc. | Transdermal formulations for delivery of capsaicinoids |
EP3337482A4 (en) * | 2015-08-17 | 2019-03-20 | Delivra Inc. | TRANSDERMAL FORMULATIONS FOR THE DISTRIBUTION OF BERBERIN COMPOUNDS AND THEIR USE IN THE TREATMENT OF BERBER INDEPENDENT ILLNESSES AND DISORDERS |
CA2997220A1 (en) * | 2015-09-03 | 2017-03-09 | Delivra Inc. | Transdermal formulations for delivery of doxycycline, and their use in the treatment of doxycycline-responsive diseases and conditions |
CA2997842A1 (en) * | 2015-09-18 | 2017-03-23 | Delivra Inc. | Transdermal formulations for delivery of propionic and acetic acid nsaids, and their use in the treatment of nsaid-responsive diseases and conditions |
EP3458031A4 (en) * | 2016-05-16 | 2020-01-22 | Delivra Inc. | TRANSDERMAL FORMULATIONS FOR THE DELIVERY OF CELECOXIB AND THEIR USE IN THE TREATMENT OF CELCOXIB-SENSITIVE DISEASES AND CONDITIONS |
EP3332768A1 (en) * | 2016-12-06 | 2018-06-13 | INDENA S.p.A. | Powder solid compositions comprising flavonoids, process for their preparation, formulations and use thereof |
WO2019075558A1 (en) | 2017-10-16 | 2019-04-25 | Delivra Inc. | TRANSDERMIC FORMULATION FOR THE ADMINISTRATION OF HYDROPHOBIC COMPOUNDS AND PROCESS FOR THE PREPARATION THEREOF |
US11142492B2 (en) * | 2019-08-26 | 2021-10-12 | Wisconsin Alumni Research Foundation | Methods of isolating phenols from phenol-containing media |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE2952115C2 (de) * | 1979-12-22 | 1982-05-06 | A. Nattermann & Cie GmbH, 5000 Köln | Rosmarinsäure-Phospholipid-Komplex |
JPS60208910A (ja) * | 1984-03-31 | 1985-10-21 | Green Cross Corp:The | 水難溶性薬物・リン脂質複合体の製造方法 |
US4769508A (en) * | 1984-12-18 | 1988-09-06 | Atlantic Richfield Company | Alkali promoted manganese oxide compositions containing titanium |
IT1215291B (it) * | 1985-07-17 | 1990-01-31 | Inverni Della Beffa Spa | Complessi di flavanolignani con fosfolipidi, loro preparazione e relative composizioni farmaceutiche. |
IT1187687B (it) * | 1985-07-17 | 1987-12-23 | Inverni Della Beffa Spa | Composizioni farmaceutiche contenenti come principi attivi flavanolignani e fosfolipidi |
IT1201151B (it) * | 1987-01-14 | 1989-01-27 | Indena Spa | Complessi fosfolipidici con estratti da vitis vinifera,procedimento per la loro preparazione e composizioni che li cntengono |
JPH01152632A (ja) * | 1987-12-09 | 1989-06-15 | Nec Corp | 半導体組立装置 |
-
1987
- 1987-01-14 IT IT19081/87A patent/IT1201149B/it active
-
1988
- 1988-01-04 DE DE88100022T patent/DE3883016T2/de not_active Expired - Fee Related
- 1988-01-04 AT AT88100022T patent/ATE92929T1/de not_active IP Right Cessation
- 1988-01-04 ES ES88100022T patent/ES2058139T3/es not_active Expired - Lifetime
- 1988-01-04 EP EP88100022A patent/EP0275005B1/en not_active Expired - Lifetime
- 1988-01-12 US US07/143,470 patent/US5043323A/en not_active Expired - Lifetime
- 1988-01-13 JP JP63006745A patent/JP2848827B2/ja not_active Expired - Fee Related
-
1995
- 1995-10-12 HK HK160995A patent/HK160995A/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
DE3883016D1 (de) | 1993-09-16 |
EP0275005A2 (en) | 1988-07-20 |
EP0275005A3 (en) | 1989-10-04 |
ATE92929T1 (de) | 1993-08-15 |
JP2848827B2 (ja) | 1999-01-20 |
IT1201149B (it) | 1989-01-27 |
DE3883016T2 (de) | 1993-11-25 |
IT8719081A0 (it) | 1987-01-14 |
JPS63198693A (ja) | 1988-08-17 |
US5043323A (en) | 1991-08-27 |
HK160995A (en) | 1995-10-20 |
EP0275005B1 (en) | 1993-08-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES2058139T3 (es) | Compuestos complejos de bioflavonoides con fosfolipidos, su preparacion y uso, y composiciones farmaceuticas y cosmeticas que los contienen. | |
ES2058151T3 (es) | Complejos de saponinas con fosfolipidos y composiciones farmaceuticas y cosmeticas que los contienen. | |
AR005703A1 (es) | Oxazolidinonas sustituidas, procedimiento para su preparacion, uso de las mismas para preparar medicamentos y medicamentos que las contienen | |
ES2058420T3 (es) | Preparados farmaceuticos combinados y su utilizacion como medicamentos antineoplasicos. | |
SE9704545D0 (sv) | Novel compounds | |
DK1036059T3 (da) | Adamantanderivater | |
MX9400166A (es) | Microesferas de proteina vegetal, hidrolizada, modificada y metodos para su preparacion y su uso. | |
AR004134A1 (es) | Derivados 2-amino-6-anilino-purina y procedimiento y nuevos intermediarios para su preparacion, formulaciones farmaceuticas que comprenden talesderivados y el uso de estos derivados como medicamentos. | |
FI953442A (fi) | Gonadotropiinia sisältäviä pakastekuivattuja pallosia | |
ES2081366T3 (es) | Uso de la il-7 en la preparacion de medicaciones para estimular la produccion de plaquetas. | |
AR003427A1 (es) | Péptidos relacionados con dolastatina, procedimiento para prepararlos, composiciones farmacéuticas que los contienen y el uso de los mismos para la preparación de dichas composiciones farmacéuticas. | |
MX9300407A (es) | Derivados azabiciclicos usados en la fabricacion de medicamentos, composiciones que los contienen y procedimiento para su preparacion. | |
ES2144239T3 (es) | Derivados de vitamina d con sustituyentes en c-25, procedimiento para su preparacion, productos intermedios y la utilizacion para la preparacion de medicamentos. | |
ES2192680T3 (es) | Nuevos derivados de vitamina d con sustituyentes carbo- o heterociclicos en c-25, procedimiento para su preparacion, productos intermedios y la utilizacion para la preparacion de medicamentos. | |
ES2157886T3 (es) | Composiciones tensioactivas y procedimientos. | |
ES2057225T3 (es) | Una composicion para la preparacion de una vitamina d3 activa en forma de dosificacion y su procedimiento de preparacion. | |
ES2063767T3 (es) | Esteres aromaticos policiclicos de antibioticos macrolidicos y lincosamidicos, su procedimiento de preparacion y composiciones farmaceuticas y cosmeticas que los contienen. | |
IL58103A0 (en) | Sila-substituted 1,4-dihydropyridine derivatives their production and pharmaceutical compositions containing them | |
ES2127263T3 (es) | Nuevos trien-derivados cromenicos, su procedimiento de preparacion y composiciones farmaceuticas que los contienen. | |
ES2129893T3 (es) | Dinucleosido-5',5'-pirofosfatos. | |
ES2089286T3 (es) | Nuevas 2-amino-5-ciano-1,4-dihidropiridinas, procedimiento para su preparacion y su uso en medicamentos. | |
FR2597478B1 (fr) | Benzimidazoles et imidazopyridines sulfonamides, leur preparation et leur application en tant que medicaments. | |
UY26517A1 (es) | Pirazolo (4,3-e) diazepinas sustituidas novedosas, composiciones farmacéuticas que las contienen, su uso como productos medicinales y procesos para prepararlas | |
ES2118248T3 (es) | Esteres y amidas de 9-cloro-prostaglandina y su empleo para preparar medicamentos. | |
ES2036532T3 (es) | Nucleosidos de isohexida, procedimientos para su preparacion y su uso como medicamentos. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG2A | Definitive protection |
Ref document number: 275005 Country of ref document: ES |